Impinj, Inc. — Q3 2021 Form 10-Q
Business context and period. Impinj develops and sells RAIN RFID products, principally endpoint integrated circuits (ICs) and systems (reader ICs, readers, gateways and software). This unaudited report covers the quarter and nine months ended September 30, 2021; comparisons are with the corresponding 2020 periods. Amounts below are in U.S. dollars.
Financial performance
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Revenue | $45.2m | $28.2m | $137.7m | $102.5m |
| Gross profit / margin | $23.0m / 50.9% | $13.4m / 47.4% | $69.8m / 50.7% | $47.7m / 46.6% |
| Operating loss | $(12.4)m | $(13.0)m | $(29.6)m | $(32.7)m |
| Net loss | $(12.9)m | $(14.3)m | $(31.2)m | $(36.2)m |
| Adjusted EBITDA (non-GAAP) | $(0.4)m | $(6.2)m | $3.8m | $(8.4)m |
Q3 revenue grew about 60% year over year; nine-month revenue grew about 34%. Endpoint ICs generated $32.0m of Q3 revenue and systems $13.2m. Higher shipment volumes drove growth, while endpoint IC revenue was partly offset by lower average selling prices. Nine-month diluted loss per share was $1.30, versus $1.60 in 2020.
Cash flow and liquidity: For the first nine months, operating cash flow was $10.4m, versus a $13.6m use in 2020, with management citing working-capital benefits, particularly lower cash use for inventory purchases. Investing cash flow was $19.4m, including $70.0m of investment maturities and $14.2m of property and equipment purchases. Financing cash flow was $11.8m, mainly from stock-option exercises and the employee stock purchase plan. At September 30, cash and cash equivalents were $65.2m and short-term investments $48.2m, totaling $113.3m; working capital was $55.8m.
Debt and obligations: The company had $86.3m principal amount of 2.00% convertible notes due 2026, with a carrying value of $84.1m. Notes became convertible at holders’ option as of September 30 after the share-price conversion threshold was met. The balance sheet classifies the carrying amount as current. Contractual obligations totaled $144.9m, including $31.2m of purchase commitments, principally inventory; $28.9m of inventory purchases were non-cancelable commitments.
Material changes and unusual items
- Gross margin improved year over year, reflecting product mix and sales of fully reserved inventory; nine-month 2021 margin also benefited from prior-year inventory excess and obsolescence charges. Sales of fully reserved inventory lifted gross margin by 2.0 percentage points in Q3 and 1.4 points for the nine-month period.
- Operating expenses rose to $35.4m in Q3 from $26.4m, notably due to higher stock-based compensation, R&D and personnel costs, product development, infrastructure and non-settlement legal fees. Nine-month stock-based compensation was $29.0m, versus $15.5m.
- Impinj adopted ASU 2020-06 on January 1, 2021, changing convertible-note accounting and reducing reported interest expense versus 2020; prior periods were not restated. Adoption reduced equity by $29.3m through accounting adjustments.
- A February 2021 go-to-market restructuring eliminated about seven positions (approximately 2% of the workforce) and incurred $1.3m of costs; it was substantially completed by June.
Outlook, management commentary and risks
- No formal numerical revenue or earnings guidance is provided in the supplied filing text. Management said existing cash, cash equivalents and short-term investments should cover anticipated cash needs for at least 12 months.
- Management reported strong endpoint IC and systems demand, but said supply constraints limited the ability to serve it. Wafer availability was tight, prebuilt endpoint IC inventory was mostly consumed by quarter-end, and 300mm post-processing capacity remained insufficient. The foundry partner indicated tight availability into 2022; Impinj reported commitments through at least mid-2022, with later supply less certain.
- Systems output was also constrained by reader-IC packaging delays and shortages and cost increases for other components. Management expected reader-IC lead times and demand fulfillment to stabilize in Q1 2022, while component constraints and price increases could continue.
- Impinj began raising prices in October 2021 to offset higher input costs. Management cautioned that margins could remain volatile due to product mix, cost inflation and the timing and success of price changes.
- COVID-19 continued to disrupt suppliers, production, travel, sales activity and customer deployments. Management said the effects were difficult to predict and expected disruption could continue into 2022.
- Key business risks include wafer and component shortages, dependence on third-party manufacturers and a small number of customers, channel visibility limitations, uncertain RAIN adoption and retail demand, competition, pricing pressure, and the company’s history of losses and fluctuating results.
- Impinj and NXP were involved in multiple U.S. and China patent disputes. The filing states outcomes are uncertain; no contingency liability was accrued at September 30. A shareholder derivative settlement remained subject to final court approval, with insurers agreeing to cover up to $0.9m of plaintiffs’ fees and expenses.
Most important facts for investors to verify
- Whether wafer supply, 300mm processing capacity and systems components improve enough to meet demand, particularly after the disclosed mid-2022 supply commitments.
- Whether October price increases offset higher costs without weakening demand, market share or gross margins.
- How much of the revenue and margin improvement reflects sustainable demand and mix versus sales of fully reserved inventory and prior-year comparison effects.
- The timing and potential financial or operational consequences of convertible-note conversion and the NXP patent litigation.
- Whether operating cash generation can continue as the company invests in growth and manages purchase commitments and ongoing losses.